INGR vs MDLZ

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on INGR as a result. In 48 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

The Moving Average Convergence Divergence (MACD) for INGR just turned positive on October 05, 2026. Looking at past instances where INGR's MACD turned positive, the stock continued to rise in 17 of 39 cases over the following month. The odds of a continued upward trend are 44%.

Following a +1.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where INGR advanced for three days, in 146 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.

INGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 56 cases where INGR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 52%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INGR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

The Aroon Indicator for INGR entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.319) is normal, around the industry mean (1.728). P/E Ratio (10.266) is within average values for comparable stocks, (6.556). Projected Growth (PEG Ratio) (1.109) is also within normal values, averaging (8.458). Dividend Yield (0.035) settles around the average of (0.056) among similar stocks. P/S Ratio (0.878) is also within normal values, averaging (4.925).

The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. INGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MDLZ as a result. In 55 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.

The Moving Average Convergence Divergence (MACD) for MDLZ just turned positive on October 08, 2026. Looking at past instances where MDLZ's MACD turned positive, the stock continued to rise in 24 of 44 cases over the following month. The odds of a continued upward trend are 55%.

MDLZ moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDLZ advanced for three days, in 166 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.

MDLZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for MDLZ moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 22 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 51%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

The Aroon Indicator for MDLZ entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. MDLZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.123) is normal, around the industry mean (1.624). P/E Ratio (23.878) is within average values for comparable stocks, (14.674). Projected Growth (PEG Ratio) (0.891) is also within normal values, averaging (1.364). Dividend Yield (0.032) settles around the average of (0.152) among similar stocks. P/S Ratio (2.028) is also within normal values, averaging (1.937).